Asset

Total 158, page 6/8

No. Organization Therapeutic Area Product Type Title
58 Alborada Drug Discovery Institute Neurology, CNS disease Small molecule eIF2B inhibition prevents neurodegeneration
57 Alborada Drug Discovery Institute Neurology, CNS disease Small molecule Nuak1 inhibitor_Neurodegenerative disease
56 Yale University Genetic disorders Protein New Modality for the treatment of ADPKD
55 Yale University Metabolic disease Nucleotide MicroRNA-based Therapeutic for NASH
54 Yale University Oncology Nucleotide Antisense-based Cancer Therapeutic
53 Yale University Oncology Nucleotide A Novel piRNA-based Drug Candidate for Hepatocellular Carcinoma (HCC)
52 Yale University Oncology Small molecule Small Molecule Inhibitors of KDM5 histone demethylases
51 Yale University Oncology Cell therapy Universal Cancer Vaccine_Cancer
50 Yale University Oncology Gene therapy Oncolytic virus_Brain Cancer
49 Walter and Eliza Hall Immunology Peptide CD52_Autoimmune diseases
48 Walter and Eliza Hall Immunology Small molecule RIPK2 inhibitor_IBD
47 Walter and Eliza Hall Immunology Small molecule Targeting plasmacytoid dendritic cells for systemic lupus erythematosus
46 University of Western Austrailia Oncology Protein Tumour ECM-targeted Tumour Necrosis Factor (TNF) alpha
45 University of Western Austrailia Oncology Protein LIGHT (TNFSF14) cytokine_Cancer
44 University of Southern California Neurology, CNS disease Small molecule C9ORF72 protein_ALS and other Neurological diseases
43 University of Southern California Oncology Antibody CpG anti-PD-L1 Immunoconjugate for Cancer Therapy
42 University of Pennsylvania Oncology Vaccine Tumor mitochondria vaccine for the treatment of cancer
41 University of Pennsylvania Metabolic disease Peptide GFANT: Novel peptides that enhance or suppress the activity of a cytokine associated with obesity and nausea
40 University of Illinois at Chicago Oncology Small molecule SERDs with Brain Penetration for Advanced Breast Cancer
39 University of Illinois at Chicago Immunology, Oncology Small molecule DF-132, HDAC6 Selective Inhibitor

TOP